Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
NCT07837973
This study is recruiting at 20 US sites in 14 states, according to its ClinicalTrials.gov record last updated .
Summary
A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with incretin-based therapies.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Overweight , Obesity
- Adults
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Alveus Therapeutics, Inc.
- Last updated on ClinicalTrials.gov
- October 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama - Birmingham · Birmingham, AL
Arizona · 2
- DM Clinical Research · Sun City, AZ
- AMR Clinical · Tempe, AZ
California · 1
- Profound Research · Oceanside, CA
Florida · 3
- DM Clinical Research · Bradenton, FL
- DM Clinical Research · Doral, FL
- Clinical Neuroscience Solutions · Orlando, FL
Georgia · 1
- North Georgia Clinical Research · Woodstock, GA
Illinois · 1
- Christie Clinic · Champaign, IL
Louisiana · 1
- BRCR Global Louisiana · Gretna, LA
Michigan · 1
- Profound Research · Farmington Hills, MI
New York · 1
- ALSA Research-Manhattan · New York, NY
North Carolina · 1
- TMA Headlands · Wilmington, NC
Oklahoma · 1
- Lynn Health Science Institute · Oklahoma City, OK
Tennessee · 1
- AMR Clinical · Nashville, TN
Texas · 4
- DM Clinical Research · Irving, TX
- DM Clinical Research - Dominion Family Healthcare · San Antonio, TX
- Tekton Research · San Antonio, TX
- DM Clinical Research · Tomball, TX
Utah · 1
- AMR Clinical · South Jordan, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.